Pediatric Acute Respiratory Distress Syndrome Workup
- Author: Prashant Purohit, MD; Chief Editor: Timothy E Corden, MD more...
The diagnosis of ARDS is established based on the definitions described above, Berlin definition for adults and The Pediatric Acute Lung Injury Consensus Conference Group definition of PARDS for children. Chest imaging including a radiograph and/or a computed tomogram are part of both the definitions. Rest of the work up is usually geared towards identification of underlying disease, assessment of ARDS progress, prevention and treatment of co-morbidities and the other aspects of ongoing management as discussed below.
Chest radiography may be useful beyond its use as part of the diagnostic criteria, as discussed below in radiography section. Computed tomography (CT) of the chest, although not routinely performed, may be helpful in differentiating between atelectasis and consolidation. Ultrasonography is an easy method of further assessing pleural effusions and differentiating between transudative and exudative fluid. Echocardiography may help exclude cardiogenic edema and would provide information regarding cardiac contractility, intraventricular volume, pulmonary hypertension, and other potential anatomic abnormalities. There appears at present to be no particular indication for magnetic resonance imaging (MRI). Other laboratory work up including hematology and blood chemistry would help identify involvement of the other organ system and further management accordingly. Persistent regional areas of atelectasis may suggest the use of bronchoscopy including bronchoalveolar lavage (BAL) for diagnostic and therapeutic consideration. Routine use of BAL is not recommended in ARDS. Indications, risks and yield of the procedure should be determined by the treating physician. Similarly, there are no specific guidelines for other laboratory work up. Utility of the other tests should be determined by treating physician.
The only role for chest ultrasonography in patients with ARDS is to define the presence of pleural effusions and to determine whether loculation of the pleural fluid is present if drainage of the effusion is being considered.
To the authors’ knowledge, no data are available concerning the role of MRI in patients with ARDS.
The primary role of echocardiography in ARDS is to detect congenital or acquired heart disease as a cause of respiratory distress and pulmonary edema. Echocardiography may provide evidence of pulmonary hypertension; however, the practical implications of this finding are unclear, because little evidence supports the clinical benefit of pulmonary vasodilators in ARDS.
Many authorities debate the use of determining pulmonary mechanics as a means of defining optimal ventilatory strategies. As of yet, no clear consensus on their use has been established.
Three classic histopathologic phases of ARDS are described. These correspond to the time course of the disease.
Typical histologic appearances of the exudative phase include diffuse hemorrhage, edema, leukocyte infiltration, and cellular necrosis or apoptosis. Evidence of the initiating illness may also be apparent, such as pneumonia or aspiration.
The main features of the proliferative phase include fibroblast proliferation, hyperplasia of type II pneumocytes, and ongoing evidence of inflammation.
The fibrotic phase is characterized by the presence of fibrosis, honeycombing, and bronchiectasis.
Suggested laboratory tests include arterial blood gas (ABG) measurements, a complete blood count (CBC) with differential, and an electrolyte panel with blood urea nitrogen (BUN) and creatinine.
Arterial blood gas measurements
Measurement of P/F ratio is an essential part of Berlin definition. However, the Pediatric Acute Lung Injury Consensus Conference group has recommended utilization of oxygen saturation and OSI. This would eliminate the burden of invasive tests in pediatric population. In case of presence of arterial catheter, the group also recommended utilizing OI ratio. All these parameters (P/F ratio, OI and OSI) will also help identify the severity of ARDS.
The onset of capillary congestion and changes in the alveolar epithelium during the initial exudative stage leads to significant ventilation/perfusion (V/Q) mismatching and intrapulmonary shunting. During this stage of ARDS, oxygen diffusion is impeded to a much greater extent than carbon dioxide diffusion. Respiratory alkalosis reflecting a relative hyperventilation and hypocarbia is an early sign of ALI/ARDS. This difference is attributable to the much greater solubility of carbon dioxide. Hypercarbia develops with worsening disease, reflecting an increasing shunt fraction and an increased dead space.
Complete blood count
The CBC may indicate an infectious etiology. Leukocytosis may be evident, reflecting either the initiating stimulus or a nonspecific inflammatory response. The CBC may also uncover significant anemia, which will further compromise oxygen-carrying capacity. Anemia may secondary to acute illness, underlying chronic disease, acute blood loss, or hemodilution from massive fluid resuscitation. Thrombocytopenia may be present.
An electrolyte panel may also screen intravascular volume status, anion gap acidosis, and other potential comorbidities. Additional laboratory tests would be indicated pending specific concerns toward individual patients.
Chest radiography is essential for diagnosing ARDS or ALI. The radiologic findings in ARDS are nonspecific (see the images below). Radiographic findings immediately after the inciting event may be entirely normal or may show only the primary disease process. Early changes reflect increased pulmonary alveolar and endothelial permeability. Studies of pediatric and adult patients reveal low levels of interobserver agreement for radiographs obtained early in the course.
Subsequently, progressive bilateral interstitial and alveolar infiltrates develop without cardiomegaly (see the images below).
As the disease progresses, the lung fields become diffusely and homogeneously opaque. However, this homogeneous appearance is misleading, as chest CT scanning demonstrates. Although the radiographic appearance may initially be indistinguishable from that observed in cardiac failure, numerous characteristic differences are present.
ARDS-related edema and edema secondary to heart failure may be difficult to distinguish on radiographs. Cardiomegaly is not a feature of ARDS; it is usually present with marked cardiac failure. Kerley B lines, which indicate interstitial edema or lymphatic swelling, are rarely observed in ARDS.
Other radiologic differential diagnoses of the infiltrates observed in ARDS include aspiration, hemorrhage, pneumonia, and atelectasis. Distinguishing these entities on the basis of chest radiographic appearances is often difficult. As opacification of the lung fields increases, air bronchograms may become apparent.
Air-leak syndromes are commonly observed on plain chest radiographs of patients with ARDS. These include pneumothorax (see the image below), pneumomediastinum, pneumopericardium, subcutaneous emphysema (see the image below), pneumoperitoneum, and pneumoretroperitoneum (free air in the retroperitoneal space).
In intubated patients, free air rises to the high caudal areas overlying the diaphragm because of their supine position. Early and subtle signs suggestive of free air include the deep sulcus sign, which is increased radiolucency in the costophrenic angle of the affected side and increased acuteness of the costophrenic angle on the same side.
The double-diaphragm sign is also reported in association with air leaks; subpulmonic air produces the impression of a second diaphragm formed by the basal border of the lower lobe. Air below the diaphragm, which does not cross the midline, suggests pneumoretroperitoneum.
Characteristic radiologic changes of late ARDS corresponding to histopathologic changes are well described. After a variable period (ie, usually days to weeks), patchy areas of increased lucency appear. Associated with clinical resolution of illness, radiologic improvement follows slowly.
Although radiologic changes completely resolve in most children, chronic changes are apparent in a small subset. Whether the persisting changes (often ascribed to fibrosis) are the result of the primary illness or ventilator-induced lung injury (VILI) is often unclear. Iatrogenic features visible on a chest radiograph in a patient with ARDS may include an endotracheal tube (see the first image below), central venous lines, and chest tubes (see the second image below).
Since CT scanning of the chest was first reported, its usefulness for understanding the pathophysiologic mechanisms underlying ARDS and the response of the ARDS lung to ventilator maneuvers has been described many times.
Gattinoni et al have been at the forefront of this research. Before the introduction of CT imaging, clinicians assumed that ARDS was a homogeneous lung process. The use of chest CT scanning demonstrated that although pulmonary involvement in ARDS was diffuse, it also was heterogeneous. In 1994, Gattinoni et al reported that, in adults with ARDS, areas of normal lung were interspersed with poorly aerated lung parenchyma.
Researchers have shown a marked spatial distribution of parenchymal collapse in the lungs of ARDS patients. In patients ventilated in a supine position, collapse was most pronounced in the more dorsal regions. A combination of edematous lung, the weight of the chest wall and mediastinal structures (specifically, the heart), and supine positioning are postulated to play a part in the development of dorsal atelectasis (see the image below). These findings provide an intellectual basis for the role of prone positioning in severe ARDS (see Treatment).
CT findings support the "baby lung" hypothesis. Simply stated, the lungs of patients with ARDS are functionally smaller than normal lungs. Indeed, some authors suggest that the volume reduction may be approximately 75% of total lung volume. Hence, ventilation with normal physiologic tidal volume may lead to iatrogenic lung damage. The data showing improved outcomes in patients with ARDS ventilated with small tidal volumes lend credence to this theory.
Gattinoni proposed 2 types of ARDS: ARDS due to primary pulmonary disease (eg, aspiration, pneumonia) and ARDS arising secondary to extrapulmonary disease (eg, sepsis, trauma).
In support of this hypothesis, Goodman et al described CT findings in adults with ARDS due to pulmonary and extrapulmonary disease and noted marked differences between populations. The group with pulmonary-related ARDS had ground-glass opacification or consolidation, which tended to be asymmetric. The group with extrapulmonary ARDS generally had symmetric ground-glass opacification.
In both groups, pleural effusions and air bronchograms were common, whereas Kerley B lines and pneumatoceles were rare. Mortality tended to increase in the group with extensive consolidation versus those with extensive ground-glass opacification; this difference was not statistically significant.
In the present clinical setting, the main use of chest CT scanning is for determining the presence of coexisting illness—specifically, thoracic abscess formation, barotrauma undefined on plain radiography, or other unsuspected pathology. CT is not routinely required for diagnosis or management of ARDS.
BAL is not required for diagnosis of ARDS. It may be useful in determining the underlying etiology in patients with primary pulmonary ARDS in whom pneumonia or an infective pneumonitis is thought to be the cause. This is especially true for immunocompromised patients. It is also used in cases of persistent regional areas of atelectasis for diagnostic and therapeutic consideration. Routine use of BAL is not recommended in ARDS. Indications, risks and yield of the procedure should be determined by the treating physician. Many investigators are interested in the use of BAL as a research tool.
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012 Jun 20. 307(23):2526-33. [Medline].
Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015 Jun. 16 (5):428-39. [Medline].
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967 Aug 12. 2 (7511):319-23. [Medline].
Petty TL, Ashbaugh DG. The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest. 1971 Sep. 60 (3):233-9. [Medline].
Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med. 1994. 20(3):225-32. [Medline].
Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994 Mar. 149 (3 Pt 1):818-24. [Medline].
Andrew B Lumb MB BS FRCA. Functional anatomy of the respiratory tract. Nunn’s Applied Respiratory Physiology. Seventh Edition. Churchill Livingstone Elsevier Ltd.; 2010. 13-26.
Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000 May 4. 342 (18):1334-49. [Medline].
Berthiaume Y, Voisin G, Dagenais A. The alveolar type I cells: the new knight of the alveolus?. J Physiol. 2006 May 1. 572 (Pt 3):609-10. [Medline].
Dos Santos CC. Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med. 2008 Apr. 34 (4):619-30. [Medline].
Sapru A, Flori H, Quasney MW, Dahmer MK, Pediatric Acute Lung Injury Consensus Conference Group. Pathobiology of acute respiratory distress syndrome. Pediatr Crit Care Med. 2015 Jun. 16 (5 Suppl 1):S6-22. [Medline].
Chen J, Chen Z, Chintagari NR, Bhaskaran M, Jin N, Narasaraju T, et al. Alveolar type I cells protect rat lung epithelium from oxidative injury. J Physiol. 2006 May 1. 572 (Pt 3):625-38. [Medline].
Erickson S, Schibler A, Numa A, Nuthall G, Yung M, Pascoe E, et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med. 2007 Jul. 8 (4):317-23. [Medline].
Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982 Jul. 144 (1):124-30. [Medline].
Fein AM, Lippmann M, Holtzman H, Eliraz A, Goldberg SK. The risk factors, incidence, and prognosis of ARDS following septicemia. Chest. 1983 Jan. 83 (1):40-2. [Medline].
Paret G, Ziv T, Augarten A, Barzilai A, Ben-Abraham R, Vardi A, et al. Acute respiratory distress syndrome in children: a 10 year experience. Isr Med Assoc J. 1999 Nov. 1 (3):149-53. [Medline].
Cullen ML. Pulmonary and respiratory complications of pediatric trauma. Respir Care Clin N Am. 2001 Mar. 7 (1):59-77. [Medline].
Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005 Jun. 33 (6):1191-8. [Medline].
Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007 May. 131 (5):1308-14. [Medline].
Neto AS, Simonis FD, Barbas CS, Biehl M, Determann RM, Elmer J, et al. Lung-Protective Ventilation With Low Tidal Volumes and the Occurrence of Pulmonary Complications in Patients Without Acute Respiratory Distress Syndrome: A Systematic Review and Individual Patient Data Analysis. Crit Care Med. 2015 Oct. 43 (10):2155-63. [Medline].
Haddad IY. Stem cell transplantation and lung dysfunction. Curr Opin Pediatr. 2013 Jun. 25 (3):350-6. [Medline].
Cooke KR. Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again. Pediatr Transplant. 2005 Dec. 9 Suppl 7:25-36. [Medline].
Panoskaltsis-Mortari A, Griese M, Madtes DK, Belperio JA, Haddad IY, Folz RJ, et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med. 2011 May 1. 183(9):1262-79. [Medline].
Li G, Malinchoc M, Cartin-Ceba R, Venkata CV, Kor DJ, Peters SG, et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med. 2011 Jan 1. 183 (1):59-66. [Medline].
Luhr OR, Antonsen K, Karlsson M, Aardal S, Thorsteinsson A, Frostell CG, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. Am J Respir Crit Care Med. 1999 Jun. 159 (6):1849-61. [Medline].
Bersten AD, Edibam C, Hunt T, Moran J, Australian and New Zealand Intensive Care Society Clinical Trials Group. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am J Respir Crit Care Med. 2002 Feb 15. 165 (4):443-8. [Medline].
Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005 Oct 20. 353 (16):1685-93. [Medline].
Zhu YF, Xu F, Lu XL, Wang Y, Chen JL, Chao JX, et al. Mortality and morbidity of acute hypoxemic respiratory failure and acute respiratory distress syndrome in infants and young children. Chin Med J (Engl). 2012 Jul. 125 (13):2265-71. [Medline].
López-Fernández Y, Azagra AM, de la Oliva P, Modesto V, Sánchez JI, Parrilla J, et al. Pediatric Acute Lung Injury Epidemiology and Natural History study: Incidence and outcome of the acute respiratory distress syndrome in children. Crit Care Med. 2012 Dec. 40 (12):3238-45. [Medline].
Kneyber MC, Brouwers AG, Caris JA, Chedamni S, Plötz FB. Acute respiratory distress syndrome: is it underrecognized in the pediatric intensive care unit?. Intensive Care Med. 2008 Apr. 34 (4):751-4. [Medline].
Zimmerman JJ, Akhtar SR, Caldwell E, Rubenfeld GD. Incidence and outcomes of pediatric acute lung injury. Pediatrics. 2009 Jul. 124 (1):87-95. [Medline].
Bindl L, Dresbach K, Lentze MJ. Incidence of acute respiratory distress syndrome in German children and adolescents: a population-based study. Crit Care Med. 2005 Jan. 33 (1):209-312. [Medline].
Moss M, Bucher B, Moore FA, Moore EE, Parsons PE. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA. 1996 Jan 3. 275 (1):50-4. [Medline].
Moazed F, Calfee CS. Environmental risk factors for acute respiratory distress syndrome. Clin Chest Med. 2014 Dec. 35 (4):625-37. [Medline].
Calfee CS, Matthay MA, Eisner MD, Benowitz N, Call M, Pittet JF, et al. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med. 2011 Jun 15. 183 (12):1660-5. [Medline].
Meyer NJ, Christie JD. Genetic heterogeneity and risk of acute respiratory distress syndrome. Semin Respir Crit Care Med. 2013 Aug. 34 (4):459-74. [Medline].
Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2012 Aug. 122 (8):2731-40. [Medline].
Gao L, Barnes KC. Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2009 May. 296 (5):L713-25. [Medline].
Wei Y, Wang Z, Su L, Chen F, Tejera P, Bajwa EK, et al. Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk. Chest. 2015 Mar. 147 (3):607-17. [Medline].
Reilly JP, Christie JD. Linking genetics to ARDS pathogenesis: the role of the platelet. Chest. 2015 Mar. 147 (3):585-6. [Medline].
Sheu CC, Zhai R, Su L, Tejera P, Gong MN, Thompson BT, et al. Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome. Eur Respir J. 2009 Mar. 33 (3):543-50. [Medline].
Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004 Jan. 30 (1):51-61. [Medline].
Erickson SE, Shlipak MG, Martin GS, Wheeler AP, Ancukiewicz M, Matthay MA, et al. Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med. 2009 Jan. 37 (1):1-6. [Medline].
Moss M, Mannino DM. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979- 1996). Crit Care Med. 2002 Aug. 30 (8):1679-85. [Medline].
Stephane Dauger, Philippe Durand, Etinne Javouey and Jean-Christophe Mercier. Acute Respiratory Distress Syndrome in Children. Pediatric Critical Care. Fourth edition. Philadelphia, PA 19103-2899.: Elsevier Saunders. Copyright 2011 by Mosby, Inc; 2011. 706-716.
Visser LH. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol. 2006 Nov. 13 (11):1203-12. [Medline].
Murray MJ, Brull SJ, Bolton CF. Brief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy. Can J Anaesth. 2006 Nov. 53 (11):1148-56. [Medline].
Gattinoni L, Bombino M, Pelosi P, Lissoni A, Pesenti A, Fumagalli R, et al. Lung structure and function in different stages of severe adult respiratory distress syndrome. JAMA. 1994 Jun 8. 271 (22):1772-9. [Medline].
Goodman LR, Fumagalli R, Tagliabue P, Tagliabue M, Ferrario M, Gattinoni L, et al. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlations. Radiology. 1999 Nov. 213 (2):545-52. [Medline].
Gorini M, Ginanni R, Villella G, Tozzi D, Augustynen A, Corrado A. Non-invasive negative and positive pressure ventilation in the treatment of acute on chronic respiratory failure. Intensive Care Med. 2004 May. 30 (5):875-81. [Medline].
Zhao X, Huang W, Li J, Liu Y, Wan M, Xue G, et al. Noninvasive Positive-Pressure Ventilation in Acute Respiratory Distress Syndrome in Patients With Acute Pancreatitis: A Retrospective Cohort Study. Pancreas. 2016 Jan. 45 (1):58-63. [Medline].
Antonelli M, Conti G, Esquinas A, Montini L, Maggiore SM, Bello G, et al. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med. 2007 Jan. 35 (1):18-25. [Medline].
Uçgun I, Yildirim H, Metintaş M, Güntülü AK. The efficacy of non-invasive positive pressure ventilation in ARDS: a controlled cohort study. Tuberk Toraks. 2010. 58 (1):16-24. [Medline].
Teague WG. Noninvasive ventilation in the pediatric intensive care unit for children with acute respiratory failure. Pediatr Pulmonol. 2003 Jun. 35 (6):418-26. [Medline].
Essouri S, Chevret L, Durand P, Haas V, Fauroux B, Devictor D. Noninvasive positive pressure ventilation: five years of experience in a pediatric intensive care unit. Pediatr Crit Care Med. 2006 Jul. 7 (4):329-34. [Medline].
Bernet V, Hug MI, Frey B. Predictive factors for the success of noninvasive mask ventilation in infants and children with acute respiratory failure. Pediatr Crit Care Med. 2005 Nov. 6 (6):660-4. [Medline].
Yañez LJ, Yunge M, Emilfork M, Lapadula M, Alcántara A, Fernández C, et al. A prospective, randomized, controlled trial of noninvasive ventilation in pediatric acute respiratory failure. Pediatr Crit Care Med. 2008 Sep. 9 (5):484-9. [Medline].
Pancera CF, Hayashi M, Fregnani JH, Negri EM, Deheinzelin D, de Camargo B. Noninvasive ventilation in immunocompromised pediatric patients: eight years of experience in a pediatric oncology intensive care unit. J Pediatr Hematol Oncol. 2008 Jul. 30 (7):533-8. [Medline].
Perry SA, Kesser KC, Geller DE, Selhorst DM, Rendle JK, Hertzog JH. Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system. Pediatr Crit Care Med. 2013 Jun. 14 (5):e250-6. [Medline].
Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008 Feb 13. 299 (6):646-55. [Medline].
Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999 Jul 7. 282 (1):54-61. [Medline].
Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998 Feb 5. 338 (6):347-54. [Medline].
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000 May 4. 342 (18):1301-8. [Medline].
Petrucci N, De Feo C. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev. 2013 Feb 28. 2:CD003844. [Medline].
Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med. 1990. 16 (6):372-7. [Medline].
Lunkenheimer PP, Rafflenbeul W, Keller H, Frank I, Dickhut HH, Fuhrmann C. Application of transtracheal pressure oscillations as a modification of "diffusing respiration". Br J Anaesth. 1972 Jun. 44 (6):627. [Medline].
High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. The HIFI Study Group. N Engl J Med. 1989 Jan 12. 320 (2):88-93. [Medline].
Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P, et al. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med. 2013 Feb 28. 368 (9):795-805. [Medline].
Young D, Lamb SE, Shah S, MacKenzie I, Tunnicliffe W, Lall R, et al. High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med. 2013 Feb 28. 368 (9):806-13. [Medline].
Arnold JH, Hanson JH, Toro-Figuero LO, Gutiérrez J, Berens RJ, Anglin DL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med. 1994 Oct. 22 (10):1530-9. [Medline].
Gupta P, Green JW, Tang X, Gall CM, Gossett JM, Rice TB, et al. Comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. JAMA Pediatr. 2014 Mar. 168 (3):243-9. [Medline].
Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007 Apr 14. 334 (7597):779. [Medline].
Curley MA, Hibberd PL, Fineman LD, Wypij D, Shih MC, Thompson JE, et al. Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA. 2005 Jul 13. 294 (2):229-37. [Medline].
Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010 Sep 16. 363 (12):1107-16. [Medline].
Willson DF, Chess PR, Notter RH. Surfactant for pediatric acute lung injury. Pediatr Clin North Am. 2008 Jun. 55 (3):545-75, ix. [Medline].
Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventós AA, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996 May 30. 334 (22):1417-21. [Medline].
Czaja AS. A critical appraisal of a randomized controlled trial: Willson et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury (JAMA 2005, 293: 470-476). Pediatr Crit Care Med. 2007 Jan. 8 (1):50-3. [Medline].
Luchetti M, Ferrero F, Gallini C, Natale A, Pigna A, Tortorolo L, et al. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med. 2002 Jul. 3 (3):261-268. [Medline].
Walmrath D, Günther A, Ghofrani HA, Schermuly R, Schneider T, Grimminger F, et al. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med. 1996 Jul. 154 (1):57-62. [Medline].
Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005 Jan 26. 293 (4):470-6. [Medline].
Thomas NJ, Hollenbeak CS, Lucking SE, Willson DF. Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure. Pediatr Crit Care Med. 2005 Mar. 6 (2):160-5. [Medline].
Furchgott RF, Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels. 1991. 28 (1-3):52-61. [Medline].
Goldman AP, Tasker RC, Hosiasson S, Henrichsen T, Macrae DJ. Early response to inhaled nitric oxide and its relationship to outcome in children with severe hypoxemic respiratory failure. Chest. 1997 Sep. 112 (3):752-8. [Medline].
Bronicki RA, Fortenberry J, Schreiber M, Checchia PA, Anas NG. Multicenter randomized controlled trial of inhaled nitric oxide for pediatric acute respiratory distress syndrome. J Pediatr. 2015 Feb. 166 (2):365-9.e1. [Medline].
Bohn D. Nitric oxide in acute hypoxic respiratory failure: from the bench to the bedside and back again. J Pediatr. 1999 Apr. 134 (4):387-9. [Medline].
Dobyns EL, Cornfield DN, Anas NG, Fortenberry JD, Tasker RC, Lynch A, et al. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999 Apr. 134 (4):406-12. [Medline].
Hirschl RB, Conrad S, Kaiser R, Zwischenberger JB, Bartlett RH, Booth F, et al. Partial liquid ventilation in adult patients with ARDS: a multicenter phase I-II trial. Adult PLV Study Group. Ann Surg. 1998 Nov. 228 (5):692-700. [Medline].
Fedora M, Nekvasil R, Seda M, Klimovic M, Dominik P. Partial liquid ventilation in the therapy of pediatric acute respiratory distress syndrome. Bratisl Lek Listy. 1999 Sep. 100 (9):481-5. [Medline].
Galvin IM, Steel A, Pinto R, Ferguson ND, Davies MW. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev. 2013 Jul 23. 7:CD003707. [Medline].
Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979 Nov 16. 242 (20):2193-6. [Medline].
Gray BW, Haft JW, Hirsch JC, Annich GM, Hirschl RB, Bartlett RH. Extracorporeal life support: experience with 2,000 patients. ASAIO J. 2015 Jan-Feb. 61 (1):2-7. [Medline].
Green TP, Timmons OD, Fackler JC, Moler FW, Thompson AE, Sweeney MF. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Crit Care Med. 1996 Feb. 24 (2):323-9. [Medline].
Brown KL, Walker G, Grant DJ, Tanner K, Ridout DA, Shekerdemian LS, et al. Predicting outcome in ex-premature infants supported with extracorporeal membrane oxygenation for acute hypoxic respiratory failure. Arch Dis Child Fetal Neonatal Ed. 2004 Sep. 89 (5):F423-7. [Medline].
Petrou S, Edwards L, UK Collaborative ECMO Trial. Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial. Arch Dis Child Fetal Neonatal Ed. 2004 May. 89 (3):F263-8. [Medline].
Bennett CC, Johnson A, Field DJ, Elbourne D, UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet. 2001 Apr 7. 357 (9262):1094-6. [Medline].
Romay E, Ferrer R. Extracorporeal CO2 removal: Technical and physiological fundaments and principal indications. Med Intensiva. 2015 Sep 29. [Medline].
Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998 Jul 8. 280 (2):159-65. [Medline].
Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006 Apr 20. 354 (16):1671-84. [Medline].
Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009 May. 37 (5):1594-603. [Medline].
Yehya N, Servaes S, Thomas NJ, Nadkarni VM, Srinivasan V. Corticosteroid exposure in pediatric acute respiratory distress syndrome. Intensive Care Med. 2015 Sep. 41 (9):1658-66. [Medline].
Kangelaris KN, Sapru A, Calfee CS, Liu KD, Pawlikowska L, Witte JS, et al. The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury. Chest. 2012 May. 141 (5):1160-9. [Medline].